LFCR FY 2020 Earnings — Lifecore Biomedical, Inc. Revenue & Financial Results | Market Cap Arena

LFCRLifecore Biomedical, Inc.

$256M

FY 2020 Earnings

Healthcare Drug Manufacturers - Specialty & Generic

Income Statement

Revenue

$160M-71.3% YoY

Gross Profit

$39M24.6% margin

Operating Income

-$26M-16.2% margin

Net Income

-$38M-23.9% margin

EPS (Diluted)

$-1.31

Cash Flow

Operating Cash Flow

-$17M

Free Cash Flow

-$44M

Stock-Based Comp.

$2,375

Balance Sheet

Total Assets

$541M

Total Liabilities

$310M

Stockholders' Equity

$231M

Cash & Equivalents

$360,000

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$160M	$558M	-71.3%
Gross Profit	$39M	$81M	-51.4%
Operating Income	-$26M	-$8M	-223.0%
Net Income	-$38M	$2M	-1899.8%